About 1 result found for searched term "400010-39-1" (0.138 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M25224 | Cantuzumab mertansine | Drug-Linker Conjugates for ADC |
| SB-408075; huC242-DM1 | ||
| Cantuzumab mertansine (SB-408075; huC242-DM1), an ADC, is an immunoconjugate of the potent maytansine derivative and the humanized monoclonal antibody (huC242) directed to CanAg. Cantuzumab mertansine has cytotoxic toward colon cancer cells and has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
